The cancer landscape has changed for patients with the introduction of targeted therapies, and a combination targeted therapy for some patients with colorectal cancer shows new promise.
Amy Setesak, B.S.N., RN, CMSRN from Memorial Sloan Kettering Cancer Center, New York, was nominated by her colleague, Aly Fox, B.S.N., RN, CMSRN, for CURE®’s Extraordinary Healer® Award.
In this essay, registered nurse Patricia Campbell of Charlene’s Dream in Daytona Beach, Florida, nominates her colleague and fellow registered nurse Eliani Berman for the 2019 CURE® Extraordinary Healer® Award.
Taylor Bell Duck was only 21 when she was diagnosed with lung cancer, a disease that is often stigmatized.
Leslie R. Schover, professor of behavioral science, The University of Texas MD Anderson Cancer Center, discusses information and education for patients regarding sexuality after treatment.
Irene Hutchins, M.D., and her patient Steve Valentine, both accomplished ballroom dancers, made a pact to dance together once he had recovered from late-stage Burkitt lymphoma. They performed their victory dance June 11 during Cancer Survivors Day at Scripps Green Hospital, in La Jolla, California, where Hutchins treated Valentine.
Young adult survivor Molly McMaster turns her experience into a national tour and non-profit group dedicated to raising awareness on colon cancer.
An essay honoring SARA SARGENTE, RN, OCN [ORANGE REGIONAL MEDICAL CENTER, MIDDLETOWN, NEW YORK]
When I returned home from my first visit to my surgeon after my diagnosis of breast cancer, I could see the look of worry on my mother's face.
SLEEPING SOUNDLY, 5-year-old Malia moved slowly in her bed, teddy and blanket close to her side.
Clinical trials can provide patients with early access to promising cancer immunotherapies.
Patients with treatment-naive CLL/SLL experienced long-term improved efficacy when treated with Brukinsa compared with bendamustine plus Rituxan.
City of Hope sets the bar for treating people, not just diseases.
Diagnosed in 2014, I share my unique aggressive treatment journey over 11 years, highlighting a common hope for more time and better treatments.
Oncology nurses tend to the needs of patients with cancer with great care, but they also tend to the unspoken needs of their patients.
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
When people tell me I have metastatic cancer, I don't let their doom and gloom stop me — I'm going to bloom like a flower.
The discussion will wrap up with perspectives on the future of CLL treatment, including anticipated improvements in patient care and quality of life, emerging therapies, and evolving patient roles in care decisions.
One person describes an oncology nurse practitioner as one to give practical advice and guidance for everyone she encounters.
For over 20 years, Dr. Brian Berryman has been a tireless advocate and compassionate care provider for those affected by multiple myeloma.
Caitlin Flanagan, a patient with HER2+ metastatic breast cancer, and Sara A. Hurvitz, M.D., discuss treatment approaches and modifications during the COVID-19 pandemic.
Marie Riehl's willingness to step outside of her professional comfort zone has allowed her to be an extraordinary patient advocate.
Patients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.
During a chemotherapy session for colon cancer, I wrote two poems about my take on cancer.
Because the five-year relative survival rate for people with esophageal cancer is approximately 22%, this makes early detection of the essence.